{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 3237, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de073-dba4-758b-bcbe-08ad83e87d71", "docSlug": "afc13b14322819221680611098a4aee7", "documentTitle": "Third Harmonic Bio | Investor Presentation Deck | 20 slides", "authorId": "third-harmonic-bio", "authorName": "Third Harmonic Bio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a timeline-based visualization to show clinical progress and pairs it with financial status.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dba4-758b-bcbe-08ad83e87d71/19", "deckHref": "/decks/019de073-dba4-758b-bcbe-08ad83e87d71", "deckAnchorHref": "/decks/019de073-dba4-758b-bcbe-08ad83e87d71#slide-19", "loopMatches": [], "arcBeatMatches": [ { "to": 19, "from": 19, "beatId": "4d0fbbb8-d858-4346-8883-bc933f36d8df", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "The Ask", "beatSlug": "sequoia-pitch-the-ask", "evidence": "Slide 19 provides a roadmap for THB001, including multiple upcoming clinical catalysts", "position": 4, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dba4-758b-bcbe-08ad83e87d71", "docSlug": "afc13b14322819221680611098a4aee7", "documentTitle": "Third Harmonic Bio | Investor Presentation Deck | 20 slides", "authorId": "third-harmonic-bio", "authorName": "Third Harmonic Bio", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dba4-758b-bcbe-08ad83e87d71/20", "deckHref": "/decks/019de073-dba4-758b-bcbe-08ad83e87d71", "deckAnchorHref": "/decks/019de073-dba4-758b-bcbe-08ad83e87d71#slide-20", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dc46-770c-87a2-2b21d91043e5", "docSlug": "4f9fcbb83e828aea5419518c9cca9ae9", "documentTitle": "Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides", "authorId": "tonix-pharmaceuticals", "authorName": "Tonix Pharmaceuticals", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": "Includes company logo, ticker symbol, conference name, and document versioning.", "imagePath": "https://imgproxy.kitesheet.com/HyZgvas8lBREMmtSlPn7QzW5yFJ8L92T0gmuaUM5mPg/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy80ZjlmY2JiODNlODI4YWVhNTQxOTUxOGM5Y2NhOWFlOS9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dc46-770c-87a2-2b21d91043e5/1", "deckHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5", "deckAnchorHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/U87kKWNlMNhoRRGI9ZhK8A0Yg6z9ShNq3TsQLSQiL9k/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy80ZjlmY2JiODNlODI4YWVhNTQxOTUxOGM5Y2NhOWFlOS9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/y2akfqQa8ge2gvLF7LLxGW8ueFCTqSxxu1bv-Fea3z8/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy80ZjlmY2JiODNlODI4YWVhNTQxOTUxOGM5Y2NhOWFlOS9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/CuWUXIXt2jp5zwYDsox_qSaPtoyYdrvLq5lgICrMni0/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy80ZjlmY2JiODNlODI4YWVhNTQxOTUxOGM5Y2NhOWFlOS9wMDAxLnBuZw" }, { "docId": "019de073-dc46-770c-87a2-2b21d91043e5", "docSlug": "4f9fcbb83e828aea5419518c9cca9ae9", "documentTitle": "Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides", "authorId": "tonix-pharmaceuticals", "authorName": "Tonix Pharmaceuticals", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dc46-770c-87a2-2b21d91043e5/2", "deckHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5", "deckAnchorHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dc46-770c-87a2-2b21d91043e5", "docSlug": "4f9fcbb83e828aea5419518c9cca9ae9", "documentTitle": "Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides", "authorId": "tonix-pharmaceuticals", "authorName": "Tonix Pharmaceuticals", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "key_messages", "function": "establish_context", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dc46-770c-87a2-2b21d91043e5/3", "deckHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5", "deckAnchorHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5#slide-3", "loopMatches": [ { "to": 29, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "e532f435-d20e-4323-8595-44dab22c3ce1", "evidence": "The presentation uses a golden circle structure to communicate the company's mission and vision", "position": 0, "objective": "Why Tonix Pharmaceuticals?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 5, "from": 3, "beatId": "cbbe0177-fd25-4450-9e5b-41d95c7043ab", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The presentation introduces the company's pipeline and key programs", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dc46-770c-87a2-2b21d91043e5", "docSlug": "4f9fcbb83e828aea5419518c9cca9ae9", "documentTitle": "Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides", "authorId": "tonix-pharmaceuticals", "authorName": "Tonix Pharmaceuticals", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "executive_summary", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dc46-770c-87a2-2b21d91043e5/4", "deckHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5", "deckAnchorHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5#slide-4", "loopMatches": [ { "to": 29, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "e532f435-d20e-4323-8595-44dab22c3ce1", "evidence": "The presentation uses a golden circle structure to communicate the company's mission and vision", "position": 0, "objective": "Why Tonix Pharmaceuticals?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 5, "from": 3, "beatId": "cbbe0177-fd25-4450-9e5b-41d95c7043ab", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The presentation introduces the company's pipeline and key programs", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dc46-770c-87a2-2b21d91043e5", "docSlug": "4f9fcbb83e828aea5419518c9cca9ae9", "documentTitle": "Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides", "authorId": "tonix-pharmaceuticals", "authorName": "Tonix Pharmaceuticals", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide provides a comprehensive overview of clinical and preclinical programs with detailed footnotes explaining specific drug statuses and licensing agreements.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dc46-770c-87a2-2b21d91043e5/5", "deckHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5", "deckAnchorHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5#slide-5", "loopMatches": [ { "to": 29, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "e532f435-d20e-4323-8595-44dab22c3ce1", "evidence": "The presentation uses a golden circle structure to communicate the company's mission and vision", "position": 0, "objective": "Why Tonix Pharmaceuticals?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 5, "from": 3, "beatId": "cbbe0177-fd25-4450-9e5b-41d95c7043ab", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The presentation introduces the company's pipeline and key programs", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dc46-770c-87a2-2b21d91043e5", "docSlug": "4f9fcbb83e828aea5419518c9cca9ae9", "documentTitle": "Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides", "authorId": "tonix-pharmaceuticals", "authorName": "Tonix Pharmaceuticals", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dc46-770c-87a2-2b21d91043e5/6", "deckHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5", "deckAnchorHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5#slide-6", "loopMatches": [ { "to": 29, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "e532f435-d20e-4323-8595-44dab22c3ce1", "evidence": "The presentation uses a golden circle structure to communicate the company's mission and vision", "position": 0, "objective": "Why Tonix Pharmaceuticals?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dc46-770c-87a2-2b21d91043e5", "docSlug": "4f9fcbb83e828aea5419518c9cca9ae9", "documentTitle": "Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides", "authorId": "tonix-pharmaceuticals", "authorName": "Tonix Pharmaceuticals", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "other", "function": "other", "notes": "The slide uses a split-layout: left side describes the drug product, right side lists clinical trial status for Fibromyalgia, Long COVID, and PTSD.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dc46-770c-87a2-2b21d91043e5/7", "deckHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5", "deckAnchorHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5#slide-7", "loopMatches": [ { "to": 29, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "e532f435-d20e-4323-8595-44dab22c3ce1", "evidence": "The presentation uses a golden circle structure to communicate the company's mission and vision", "position": 0, "objective": "Why Tonix Pharmaceuticals?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 15, "from": 7, "beatId": "7e5647ed-6856-422f-b350-52485c939d0b", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The presentation outlines the company's product candidates and their potential applications", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dc46-770c-87a2-2b21d91043e5", "docSlug": "4f9fcbb83e828aea5419518c9cca9ae9", "documentTitle": "Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides", "authorId": "tonix-pharmaceuticals", "authorName": "Tonix Pharmaceuticals", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "executive_summary", "function": "summarize", "notes": "Includes clinical trial status (RELIEF, RALLY, RESILIENT) and market demographics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dc46-770c-87a2-2b21d91043e5/8", "deckHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5", "deckAnchorHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5#slide-8", "loopMatches": [ { "to": 29, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "e532f435-d20e-4323-8595-44dab22c3ce1", "evidence": "The presentation uses a golden circle structure to communicate the company's mission and vision", "position": 0, "objective": "Why Tonix Pharmaceuticals?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 15, "from": 7, "beatId": "7e5647ed-6856-422f-b350-52485c939d0b", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The presentation outlines the company's product candidates and their potential applications", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dc46-770c-87a2-2b21d91043e5", "docSlug": "4f9fcbb83e828aea5419518c9cca9ae9", "documentTitle": "Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides", "authorId": "tonix-pharmaceuticals", "authorName": "Tonix Pharmaceuticals", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "other", "function": "present_framework", "notes": "Clinical trial design slide for Tonix Pharmaceuticals.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dc46-770c-87a2-2b21d91043e5/9", "deckHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5", "deckAnchorHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5#slide-9", "loopMatches": [ { "to": 29, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "e532f435-d20e-4323-8595-44dab22c3ce1", "evidence": "The presentation uses a golden circle structure to communicate the company's mission and vision", "position": 0, "objective": "Why Tonix Pharmaceuticals?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 15, "from": 7, "beatId": "7e5647ed-6856-422f-b350-52485c939d0b", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The presentation outlines the company's product candidates and their potential applications", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dc46-770c-87a2-2b21d91043e5", "docSlug": "4f9fcbb83e828aea5419518c9cca9ae9", "documentTitle": "Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides", "authorId": "tonix-pharmaceuticals", "authorName": "Tonix Pharmaceuticals", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "other", "function": "establish_context", "notes": "Slide 10 of a corporate presentation deck.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dc46-770c-87a2-2b21d91043e5/10", "deckHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5", "deckAnchorHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5#slide-10", "loopMatches": [ { "to": 29, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "e532f435-d20e-4323-8595-44dab22c3ce1", "evidence": "The presentation uses a golden circle structure to communicate the company's mission and vision", "position": 0, "objective": "Why Tonix Pharmaceuticals?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 15, "from": 7, "beatId": "7e5647ed-6856-422f-b350-52485c939d0b", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The presentation outlines the company's product candidates and their potential applications", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dc46-770c-87a2-2b21d91043e5", "docSlug": "4f9fcbb83e828aea5419518c9cca9ae9", "documentTitle": "Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides", "authorId": "tonix-pharmaceuticals", "authorName": "Tonix Pharmaceuticals", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "other", "function": "present_framework", "notes": "The slide outlines a clinical trial protocol for TNX-102 SL in Long COVID patients.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dc46-770c-87a2-2b21d91043e5/11", "deckHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5", "deckAnchorHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5#slide-11", "loopMatches": [ { "to": 29, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "e532f435-d20e-4323-8595-44dab22c3ce1", "evidence": "The presentation uses a golden circle structure to communicate the company's mission and vision", "position": 0, "objective": "Why Tonix Pharmaceuticals?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 15, "from": 7, "beatId": "7e5647ed-6856-422f-b350-52485c939d0b", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The presentation outlines the company's product candidates and their potential applications", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dc46-770c-87a2-2b21d91043e5", "docSlug": "4f9fcbb83e828aea5419518c9cca9ae9", "documentTitle": "Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides", "authorId": "tonix-pharmaceuticals", "authorName": "Tonix Pharmaceuticals", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "key_messages", "function": "establish_context", "notes": "Includes disclaimer about non-approval and patent status.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dc46-770c-87a2-2b21d91043e5/12", "deckHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5", "deckAnchorHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5#slide-12", "loopMatches": [ { "to": 29, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "e532f435-d20e-4323-8595-44dab22c3ce1", "evidence": "The presentation uses a golden circle structure to communicate the company's mission and vision", "position": 0, "objective": "Why Tonix Pharmaceuticals?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 15, "from": 7, "beatId": "7e5647ed-6856-422f-b350-52485c939d0b", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The presentation outlines the company's product candidates and their potential applications", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dc46-770c-87a2-2b21d91043e5", "docSlug": "4f9fcbb83e828aea5419518c9cca9ae9", "documentTitle": "Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides", "authorId": "tonix-pharmaceuticals", "authorName": "Tonix Pharmaceuticals", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "key_messages", "function": "present_solution", "notes": "Slide 13 of a Tonix Pharmaceuticals presentation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dc46-770c-87a2-2b21d91043e5/13", "deckHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5", "deckAnchorHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5#slide-13", "loopMatches": [ { "to": 29, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "e532f435-d20e-4323-8595-44dab22c3ce1", "evidence": "The presentation uses a golden circle structure to communicate the company's mission and vision", "position": 0, "objective": "Why Tonix Pharmaceuticals?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 15, "from": 7, "beatId": "7e5647ed-6856-422f-b350-52485c939d0b", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The presentation outlines the company's product candidates and their potential applications", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dc46-770c-87a2-2b21d91043e5", "docSlug": "4f9fcbb83e828aea5419518c9cca9ae9", "documentTitle": "Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides", "authorId": "tonix-pharmaceuticals", "authorName": "Tonix Pharmaceuticals", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "executive_summary", "function": "present_solution", "notes": "Includes clinical trial status and mechanism of action highlights.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dc46-770c-87a2-2b21d91043e5/14", "deckHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5", "deckAnchorHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5#slide-14", "loopMatches": [ { "to": 29, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "e532f435-d20e-4323-8595-44dab22c3ce1", "evidence": "The presentation uses a golden circle structure to communicate the company's mission and vision", "position": 0, "objective": "Why Tonix Pharmaceuticals?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 15, "from": 7, "beatId": "7e5647ed-6856-422f-b350-52485c939d0b", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The presentation outlines the company's product candidates and their potential applications", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dc46-770c-87a2-2b21d91043e5", "docSlug": "4f9fcbb83e828aea5419518c9cca9ae9", "documentTitle": "Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides", "authorId": "tonix-pharmaceuticals", "authorName": "Tonix Pharmaceuticals", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "other", "function": "present_solution", "notes": "Slide provides a high-level summary of a pharmaceutical asset's profile and development roadmap.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dc46-770c-87a2-2b21d91043e5/15", "deckHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5", "deckAnchorHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5#slide-15", "loopMatches": [ { "to": 29, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "e532f435-d20e-4323-8595-44dab22c3ce1", "evidence": "The presentation uses a golden circle structure to communicate the company's mission and vision", "position": 0, "objective": "Why Tonix Pharmaceuticals?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 15, "from": 7, "beatId": "7e5647ed-6856-422f-b350-52485c939d0b", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The presentation outlines the company's product candidates and their potential applications", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dc46-770c-87a2-2b21d91043e5", "docSlug": "4f9fcbb83e828aea5419518c9cca9ae9", "documentTitle": "Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides", "authorId": "tonix-pharmaceuticals", "authorName": "Tonix Pharmaceuticals", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dc46-770c-87a2-2b21d91043e5/16", "deckHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5", "deckAnchorHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5#slide-16", "loopMatches": [ { "to": 29, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "e532f435-d20e-4323-8595-44dab22c3ce1", "evidence": "The presentation uses a golden circle structure to communicate the company's mission and vision", "position": 0, "objective": "Why Tonix Pharmaceuticals?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 18, "from": 16, "beatId": "61540f51-24ff-44c6-af8d-84164a6e08dc", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "The presentation highlights the market potential of the company's product candidates", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dc46-770c-87a2-2b21d91043e5", "docSlug": "4f9fcbb83e828aea5419518c9cca9ae9", "documentTitle": "Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides", "authorId": "tonix-pharmaceuticals", "authorName": "Tonix Pharmaceuticals", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "other", "function": "frame_situation", "notes": "The slide uses a two-column layout to contrast the disease profile with the development program status.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dc46-770c-87a2-2b21d91043e5/17", "deckHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5", "deckAnchorHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5#slide-17", "loopMatches": [ { "to": 29, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "e532f435-d20e-4323-8595-44dab22c3ce1", "evidence": "The presentation uses a golden circle structure to communicate the company's mission and vision", "position": 0, "objective": "Why Tonix Pharmaceuticals?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 18, "from": 16, "beatId": "61540f51-24ff-44c6-af8d-84164a6e08dc", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "The presentation highlights the market potential of the company's product candidates", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dc46-770c-87a2-2b21d91043e5", "docSlug": "4f9fcbb83e828aea5419518c9cca9ae9", "documentTitle": "Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides", "authorId": "tonix-pharmaceuticals", "authorName": "Tonix Pharmaceuticals", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dc46-770c-87a2-2b21d91043e5/18", "deckHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5", "deckAnchorHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5#slide-18", "loopMatches": [ { "to": 29, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "e532f435-d20e-4323-8595-44dab22c3ce1", "evidence": "The presentation uses a golden circle structure to communicate the company's mission and vision", "position": 0, "objective": "Why Tonix Pharmaceuticals?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 18, "from": 16, "beatId": "61540f51-24ff-44c6-af8d-84164a6e08dc", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "The presentation highlights the market potential of the company's product candidates", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dc46-770c-87a2-2b21d91043e5", "docSlug": "4f9fcbb83e828aea5419518c9cca9ae9", "documentTitle": "Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides", "authorId": "tonix-pharmaceuticals", "authorName": "Tonix Pharmaceuticals", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "propose_solution", "function": "present_solution", "notes": "Includes a comparison of three generations of CD40L antibodies and a structural diagram of the antibody.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dc46-770c-87a2-2b21d91043e5/19", "deckHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5", "deckAnchorHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5#slide-19", "loopMatches": [ { "to": 29, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "e532f435-d20e-4323-8595-44dab22c3ce1", "evidence": "The presentation uses a golden circle structure to communicate the company's mission and vision", "position": 0, "objective": "Why Tonix Pharmaceuticals?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dc46-770c-87a2-2b21d91043e5", "docSlug": "4f9fcbb83e828aea5419518c9cca9ae9", "documentTitle": "Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides", "authorId": "tonix-pharmaceuticals", "authorName": "Tonix Pharmaceuticals", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "key_messages", "function": "present_solution", "notes": "The slide outlines a drug development asset in the immunology portfolio.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dc46-770c-87a2-2b21d91043e5/20", "deckHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5", "deckAnchorHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5#slide-20", "loopMatches": [ { "to": 29, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "e532f435-d20e-4323-8595-44dab22c3ce1", "evidence": "The presentation uses a golden circle structure to communicate the company's mission and vision", "position": 0, "objective": "Why Tonix Pharmaceuticals?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dc46-770c-87a2-2b21d91043e5", "docSlug": "4f9fcbb83e828aea5419518c9cca9ae9", "documentTitle": "Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides", "authorId": "tonix-pharmaceuticals", "authorName": "Tonix Pharmaceuticals", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dc46-770c-87a2-2b21d91043e5/21", "deckHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5", "deckAnchorHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5#slide-21", "loopMatches": [ { "to": 29, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "e532f435-d20e-4323-8595-44dab22c3ce1", "evidence": "The presentation uses a golden circle structure to communicate the company's mission and vision", "position": 0, "objective": "Why Tonix Pharmaceuticals?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dc46-770c-87a2-2b21d91043e5", "docSlug": "4f9fcbb83e828aea5419518c9cca9ae9", "documentTitle": "Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides", "authorId": "tonix-pharmaceuticals", "authorName": "Tonix Pharmaceuticals", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "key_messages", "function": "present_solution", "notes": "The slide uses a split-layout design with a left-hand column for platform differentiators and a right-hand column for specific product status and next steps.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dc46-770c-87a2-2b21d91043e5/22", "deckHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5", "deckAnchorHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5#slide-22", "loopMatches": [ { "to": 29, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "e532f435-d20e-4323-8595-44dab22c3ce1", "evidence": "The presentation uses a golden circle structure to communicate the company's mission and vision", "position": 0, "objective": "Why Tonix Pharmaceuticals?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dc46-770c-87a2-2b21d91043e5", "docSlug": "4f9fcbb83e828aea5419518c9cca9ae9", "documentTitle": "Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides", "authorId": "tonix-pharmaceuticals", "authorName": "Tonix Pharmaceuticals", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "propose_solution", "function": "present_solution", "notes": "The slide uses a process-like diagram to show the evolution from historical vaccines (Vaccinia, Horsepox) to a modern programmable 'Antigen Coding' platform.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dc46-770c-87a2-2b21d91043e5/23", "deckHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5", "deckAnchorHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5#slide-23", "loopMatches": [ { "to": 29, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "e532f435-d20e-4323-8595-44dab22c3ce1", "evidence": "The presentation uses a golden circle structure to communicate the company's mission and vision", "position": 0, "objective": "Why Tonix Pharmaceuticals?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dc46-770c-87a2-2b21d91043e5", "docSlug": "4f9fcbb83e828aea5419518c9cca9ae9", "documentTitle": "Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides", "authorId": "tonix-pharmaceuticals", "authorName": "Tonix Pharmaceuticals", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "other", "function": "other", "notes": "The slide lists three distinct facilities: RDC (Frederick, MD), ADC (North Dartmouth, MA), and CMC (Hamilton, MT).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dc46-770c-87a2-2b21d91043e5/24", "deckHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5", "deckAnchorHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5#slide-24", "loopMatches": [ { "to": 29, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "e532f435-d20e-4323-8595-44dab22c3ce1", "evidence": "The presentation uses a golden circle structure to communicate the company's mission and vision", "position": 0, "objective": "Why Tonix Pharmaceuticals?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dc46-770c-87a2-2b21d91043e5", "docSlug": "4f9fcbb83e828aea5419518c9cca9ae9", "documentTitle": "Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides", "authorId": "tonix-pharmaceuticals", "authorName": "Tonix Pharmaceuticals", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dc46-770c-87a2-2b21d91043e5/25", "deckHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5", "deckAnchorHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5#slide-25", "loopMatches": [ { "to": 29, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "e532f435-d20e-4323-8595-44dab22c3ce1", "evidence": "The presentation uses a golden circle structure to communicate the company's mission and vision", "position": 0, "objective": "Why Tonix Pharmaceuticals?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dc46-770c-87a2-2b21d91043e5", "docSlug": "4f9fcbb83e828aea5419518c9cca9ae9", "documentTitle": "Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides", "authorId": "tonix-pharmaceuticals", "authorName": "Tonix Pharmaceuticals", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "timeline", "function": "plan_implementation", "notes": "The slide uses checkmarks for completed items and empty squares for future items.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dc46-770c-87a2-2b21d91043e5/26", "deckHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5", "deckAnchorHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5#slide-26", "loopMatches": [ { "to": 29, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "e532f435-d20e-4323-8595-44dab22c3ce1", "evidence": "The presentation uses a golden circle structure to communicate the company's mission and vision", "position": 0, "objective": "Why Tonix Pharmaceuticals?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dc46-770c-87a2-2b21d91043e5", "docSlug": "4f9fcbb83e828aea5419518c9cca9ae9", "documentTitle": "Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides", "authorId": "tonix-pharmaceuticals", "authorName": "Tonix Pharmaceuticals", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "other", "function": "other", "notes": "The slide uses a grid-like layout to associate logos of institutions with specific TNX drug candidates.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dc46-770c-87a2-2b21d91043e5/27", "deckHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5", "deckAnchorHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5#slide-27", "loopMatches": [ { "to": 29, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "e532f435-d20e-4323-8595-44dab22c3ce1", "evidence": "The presentation uses a golden circle structure to communicate the company's mission and vision", "position": 0, "objective": "Why Tonix Pharmaceuticals?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dc46-770c-87a2-2b21d91043e5", "docSlug": "4f9fcbb83e828aea5419518c9cca9ae9", "documentTitle": "Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides", "authorId": "tonix-pharmaceuticals", "authorName": "Tonix Pharmaceuticals", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "team_bio", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dc46-770c-87a2-2b21d91043e5/28", "deckHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5", "deckAnchorHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5#slide-28", "loopMatches": [ { "to": 29, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "e532f435-d20e-4323-8595-44dab22c3ce1", "evidence": "The presentation uses a golden circle structure to communicate the company's mission and vision", "position": 0, "objective": "Why Tonix Pharmaceuticals?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [ { "to": 28, "from": 28, "beatId": "2fd3d443-3034-443c-9971-34c1bda1b747", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Team", "beatSlug": "sequoia-pitch-team", "evidence": "The presentation introduces the company's management team", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dc46-770c-87a2-2b21d91043e5", "docSlug": "4f9fcbb83e828aea5419518c9cca9ae9", "documentTitle": "Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides", "authorId": "tonix-pharmaceuticals", "authorName": "Tonix Pharmaceuticals", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "closing_ask", "function": "summarize", "notes": "Standard corporate closing slide.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dc46-770c-87a2-2b21d91043e5/29", "deckHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5", "deckAnchorHref": "/decks/019de073-dc46-770c-87a2-2b21d91043e5#slide-29", "loopMatches": [ { "to": 29, "from": 3, "name": "Golden Circle", "slug": "11-golden-circle", "bestFor": "Visionary leadership, brand positioning, mission statements", "matchId": "e532f435-d20e-4323-8595-44dab22c3ce1", "evidence": "The presentation uses a golden circle structure to communicate the company's mission and vision", "position": 0, "objective": "Why Tonix Pharmaceuticals?", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "confidence": 0.6, "description": "Invert the typical pitch by starting with why you exist, rather than what you do" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dcea-728d-951c-3245f1025a1c", "docSlug": "00ac2b00f11c51b783403963865f2f9f", "documentTitle": "Truist Financial Corp | Results Presentation Deck | 37 slides", "authorId": "truist-financial-corp", "authorName": "Truist", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/oVAJR5HiRkFQplHFw87qC9to-70ujtlsqKQpk7xej6o/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wMGFjMmIwMGYxMWM1MWI3ODM0MDM5NjM4NjVmMmY5Zi9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dcea-728d-951c-3245f1025a1c/1", "deckHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c", "deckAnchorHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c#slide-1", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "85496550-608c-47ba-91ca-d26a66c4a003", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "Introduction and key messages", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": "https://imgproxy.kitesheet.com/c4Mcus-BYo7Uf4iCV5c7hTFoOZR0ypwA6B0dAY_LUTY/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wMGFjMmIwMGYxMWM1MWI3ODM0MDM5NjM4NjVmMmY5Zi9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/6RprmjU3LfKQjweohZG5cDEmD8uonLp4RQBMi8_X2Vc/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wMGFjMmIwMGYxMWM1MWI3ODM0MDM5NjM4NjVmMmY5Zi9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/UTzP-1Rmvf_oOdlHDHL6-GdrAgdSinMfAZeqY_LCmJs/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wMGFjMmIwMGYxMWM1MWI3ODM0MDM5NjM4NjVmMmY5Zi9wMDAxLnBuZw" }, { "docId": "019de073-dcea-728d-951c-3245f1025a1c", "docSlug": "00ac2b00f11c51b783403963865f2f9f", "documentTitle": "Truist Financial Corp | Results Presentation Deck | 37 slides", "authorId": "truist-financial-corp", "authorName": "Truist", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dcea-728d-951c-3245f1025a1c/2", "deckHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c", "deckAnchorHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c#slide-2", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "85496550-608c-47ba-91ca-d26a66c4a003", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "Introduction and key messages", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dcea-728d-951c-3245f1025a1c", "docSlug": "00ac2b00f11c51b783403963865f2f9f", "documentTitle": "Truist Financial Corp | Results Presentation Deck | 37 slides", "authorId": "truist-financial-corp", "authorName": "Truist", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "appendix_disclosure", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dcea-728d-951c-3245f1025a1c/3", "deckHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c", "deckAnchorHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c#slide-3", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "85496550-608c-47ba-91ca-d26a66c4a003", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "Introduction and key messages", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dcea-728d-951c-3245f1025a1c", "docSlug": "00ac2b00f11c51b783403963865f2f9f", "documentTitle": "Truist Financial Corp | Results Presentation Deck | 37 slides", "authorId": "truist-financial-corp", "authorName": "Truist", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "key_messages", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dcea-728d-951c-3245f1025a1c/4", "deckHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c", "deckAnchorHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "85496550-608c-47ba-91ca-d26a66c4a003", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "Introduction and key messages", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dcea-728d-951c-3245f1025a1c", "docSlug": "00ac2b00f11c51b783403963865f2f9f", "documentTitle": "Truist Financial Corp | Results Presentation Deck | 37 slides", "authorId": "truist-financial-corp", "authorName": "Truist", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide uses a five-column layout to categorize impact metrics and strategic achievements.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dcea-728d-951c-3245f1025a1c/5", "deckHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c", "deckAnchorHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c#slide-5", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 1, "beatId": "85496550-608c-47ba-91ca-d26a66c4a003", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Attention", "beatSlug": "monroes-sequence-attention", "evidence": "Introduction and key messages", "position": 0, "confidence": 0.8, "parentBeatName": "Hook", "parentBeatSlug": "hook" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dcea-728d-951c-3245f1025a1c", "docSlug": "00ac2b00f11c51b783403963865f2f9f", "documentTitle": "Truist Financial Corp | Results Presentation Deck | 37 slides", "authorId": "truist-financial-corp", "authorName": "Truist", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dcea-728d-951c-3245f1025a1c/6", "deckHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c", "deckAnchorHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c#slide-6", "loopMatches": [ { "to": 16, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "499b187b-6589-4c7a-8abe-1eae2f25e7a9", "evidence": "Emphasis on shifting from integration to execution and growth", "position": 0, "objective": "Highlighting the importance of Truist's growth strategy", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 8, "from": 6, "beatId": "9ede6f14-08f3-4acf-9826-93b4367e366a", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "Financial results and performance highlights", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dcea-728d-951c-3245f1025a1c", "docSlug": "00ac2b00f11c51b783403963865f2f9f", "documentTitle": "Truist Financial Corp | Results Presentation Deck | 37 slides", "authorId": "truist-financial-corp", "authorName": "Truist", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide provides a reconciliation of specific non-GAAP items.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dcea-728d-951c-3245f1025a1c/7", "deckHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c", "deckAnchorHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c#slide-7", "loopMatches": [ { "to": 16, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "499b187b-6589-4c7a-8abe-1eae2f25e7a9", "evidence": "Emphasis on shifting from integration to execution and growth", "position": 0, "objective": "Highlighting the importance of Truist's growth strategy", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 8, "from": 6, "beatId": "9ede6f14-08f3-4acf-9826-93b4367e366a", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "Financial results and performance highlights", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dcea-728d-951c-3245f1025a1c", "docSlug": "00ac2b00f11c51b783403963865f2f9f", "documentTitle": "Truist Financial Corp | Results Presentation Deck | 37 slides", "authorId": "truist-financial-corp", "authorName": "Truist", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Includes both GAAP and Adjusted metrics with period-over-period comparisons.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dcea-728d-951c-3245f1025a1c/8", "deckHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c", "deckAnchorHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c#slide-8", "loopMatches": [ { "to": 16, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "499b187b-6589-4c7a-8abe-1eae2f25e7a9", "evidence": "Emphasis on shifting from integration to execution and growth", "position": 0, "objective": "Highlighting the importance of Truist's growth strategy", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 8, "from": 6, "beatId": "9ede6f14-08f3-4acf-9826-93b4367e366a", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Need", "beatSlug": "monroes-sequence-need", "evidence": "Financial results and performance highlights", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dcea-728d-951c-3245f1025a1c", "docSlug": "00ac2b00f11c51b783403963865f2f9f", "documentTitle": "Truist Financial Corp | Results Presentation Deck | 37 slides", "authorId": "truist-financial-corp", "authorName": "Truist", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Includes footnotes defining the metrics used in the charts.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dcea-728d-951c-3245f1025a1c/9", "deckHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c", "deckAnchorHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c#slide-9", "loopMatches": [ { "to": 16, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "499b187b-6589-4c7a-8abe-1eae2f25e7a9", "evidence": "Emphasis on shifting from integration to execution and growth", "position": 0, "objective": "Highlighting the importance of Truist's growth strategy", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 16, "from": 9, "beatId": "e7f56f8f-1d4c-4e27-a22f-dad8b6dbffe8", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "Digital care, asset quality, and capital position", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dcea-728d-951c-3245f1025a1c", "docSlug": "00ac2b00f11c51b783403963865f2f9f", "documentTitle": "Truist Financial Corp | Results Presentation Deck | 37 slides", "authorId": "truist-financial-corp", "authorName": "Truist", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "kpi_overview", "function": "analyze_data", "notes": "HFI = Held for Investment; C&I = Commercial & Industrial; PAA = Purchase Accounting Adjustment; CRE = Commercial Real Estate; PPP = Paycheck Protection Program.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dcea-728d-951c-3245f1025a1c/10", "deckHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c", "deckAnchorHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c#slide-10", "loopMatches": [ { "to": 16, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "499b187b-6589-4c7a-8abe-1eae2f25e7a9", "evidence": "Emphasis on shifting from integration to execution and growth", "position": 0, "objective": "Highlighting the importance of Truist's growth strategy", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 16, "from": 9, "beatId": "e7f56f8f-1d4c-4e27-a22f-dad8b6dbffe8", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "Digital care, asset quality, and capital position", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dcea-728d-951c-3245f1025a1c", "docSlug": "00ac2b00f11c51b783403963865f2f9f", "documentTitle": "Truist Financial Corp | Results Presentation Deck | 37 slides", "authorId": "truist-financial-corp", "authorName": "Truist", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide includes a footnote explaining the cumulative beta calculation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dcea-728d-951c-3245f1025a1c/11", "deckHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c", "deckAnchorHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c#slide-11", "loopMatches": [ { "to": 16, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "499b187b-6589-4c7a-8abe-1eae2f25e7a9", "evidence": "Emphasis on shifting from integration to execution and growth", "position": 0, "objective": "Highlighting the importance of Truist's growth strategy", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 16, "from": 9, "beatId": "e7f56f8f-1d4c-4e27-a22f-dad8b6dbffe8", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "Digital care, asset quality, and capital position", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dcea-728d-951c-3245f1025a1c", "docSlug": "00ac2b00f11c51b783403963865f2f9f", "documentTitle": "Truist Financial Corp | Results Presentation Deck | 37 slides", "authorId": "truist-financial-corp", "authorName": "Truist", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Includes breakdown of Core net interest income vs Purchase accounting accretion (PAA) and Reported NIM vs Core NIM.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dcea-728d-951c-3245f1025a1c/12", "deckHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c", "deckAnchorHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c#slide-12", "loopMatches": [ { "to": 16, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "499b187b-6589-4c7a-8abe-1eae2f25e7a9", "evidence": "Emphasis on shifting from integration to execution and growth", "position": 0, "objective": "Highlighting the importance of Truist's growth strategy", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 16, "from": 9, "beatId": "e7f56f8f-1d4c-4e27-a22f-dad8b6dbffe8", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "Digital care, asset quality, and capital position", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dcea-728d-951c-3245f1025a1c", "docSlug": "00ac2b00f11c51b783403963865f2f9f", "documentTitle": "Truist Financial Corp | Results Presentation Deck | 37 slides", "authorId": "truist-financial-corp", "authorName": "Truist", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Includes a small data table at the bottom for 'Other income detail' and a stacked bar chart showing fee income ratio.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dcea-728d-951c-3245f1025a1c/13", "deckHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c", "deckAnchorHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c#slide-13", "loopMatches": [ { "to": 16, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "499b187b-6589-4c7a-8abe-1eae2f25e7a9", "evidence": "Emphasis on shifting from integration to execution and growth", "position": 0, "objective": "Highlighting the importance of Truist's growth strategy", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 16, "from": 9, "beatId": "e7f56f8f-1d4c-4e27-a22f-dad8b6dbffe8", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "Digital care, asset quality, and capital position", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dcea-728d-951c-3245f1025a1c", "docSlug": "00ac2b00f11c51b783403963865f2f9f", "documentTitle": "Truist Financial Corp | Results Presentation Deck | 37 slides", "authorId": "truist-financial-corp", "authorName": "Truist", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a stacked bar chart to show expense composition and overlay markers for efficiency ratios.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dcea-728d-951c-3245f1025a1c/14", "deckHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c", "deckAnchorHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c#slide-14", "loopMatches": [ { "to": 16, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "499b187b-6589-4c7a-8abe-1eae2f25e7a9", "evidence": "Emphasis on shifting from integration to execution and growth", "position": 0, "objective": "Highlighting the importance of Truist's growth strategy", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 16, "from": 9, "beatId": "e7f56f8f-1d4c-4e27-a22f-dad8b6dbffe8", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "Digital care, asset quality, and capital position", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dcea-728d-951c-3245f1025a1c", "docSlug": "00ac2b00f11c51b783403963865f2f9f", "documentTitle": "Truist Financial Corp | Results Presentation Deck | 37 slides", "authorId": "truist-financial-corp", "authorName": "Truist", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a consistent color palette and layout to compare credit performance metrics across time.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dcea-728d-951c-3245f1025a1c/15", "deckHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c", "deckAnchorHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c#slide-15", "loopMatches": [ { "to": 16, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "499b187b-6589-4c7a-8abe-1eae2f25e7a9", "evidence": "Emphasis on shifting from integration to execution and growth", "position": 0, "objective": "Highlighting the importance of Truist's growth strategy", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 16, "from": 9, "beatId": "e7f56f8f-1d4c-4e27-a22f-dad8b6dbffe8", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "Digital care, asset quality, and capital position", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dcea-728d-951c-3245f1025a1c", "docSlug": "00ac2b00f11c51b783403963865f2f9f", "documentTitle": "Truist Financial Corp | Results Presentation Deck | 37 slides", "authorId": "truist-financial-corp", "authorName": "Truist", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Includes preliminary regulatory capital information.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dcea-728d-951c-3245f1025a1c/16", "deckHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c", "deckAnchorHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c#slide-16", "loopMatches": [ { "to": 16, "from": 6, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "499b187b-6589-4c7a-8abe-1eae2f25e7a9", "evidence": "Emphasis on shifting from integration to execution and growth", "position": 0, "objective": "Highlighting the importance of Truist's growth strategy", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 16, "from": 9, "beatId": "e7f56f8f-1d4c-4e27-a22f-dad8b6dbffe8", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "Digital care, asset quality, and capital position", "position": 2, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dcea-728d-951c-3245f1025a1c", "docSlug": "00ac2b00f11c51b783403963865f2f9f", "documentTitle": "Truist Financial Corp | Results Presentation Deck | 37 slides", "authorId": "truist-financial-corp", "authorName": "Truist", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "comparison_table", "function": "analyze_data", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dcea-728d-951c-3245f1025a1c/17", "deckHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c", "deckAnchorHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c#slide-17", "loopMatches": [ { "to": 26, "from": 17, "name": "Hypothesis Test", "slug": "42-hypothesis-test", "bestFor": "Strategy validation, due diligence, research presentations", "matchId": "af624d3e-dc9e-461f-9693-74b58a80801b", "evidence": "Acquisition details and financial projections", "position": 1, "objective": "Providing evidence and projections to support growth strategy", "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)", "confidence": 0.6, "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence" } ], "arcBeatMatches": [ { "to": 37, "from": 17, "beatId": "5dcf97d8-ba04-4814-afdf-fb959b01651c", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "Growth strategy, acquisition details, and financial projections", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dcea-728d-951c-3245f1025a1c", "docSlug": "00ac2b00f11c51b783403963865f2f9f", "documentTitle": "Truist Financial Corp | Results Presentation Deck | 37 slides", "authorId": "truist-financial-corp", "authorName": "Truist", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "timeline", "function": "summarize", "notes": "The slide uses checkmarks to indicate the active focus areas for each year.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dcea-728d-951c-3245f1025a1c/18", "deckHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c", "deckAnchorHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c#slide-18", "loopMatches": [ { "to": 26, "from": 17, "name": "Hypothesis Test", "slug": "42-hypothesis-test", "bestFor": "Strategy validation, due diligence, research presentations", "matchId": "af624d3e-dc9e-461f-9693-74b58a80801b", "evidence": "Acquisition details and financial projections", "position": 1, "objective": "Providing evidence and projections to support growth strategy", "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)", "confidence": 0.6, "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence" } ], "arcBeatMatches": [ { "to": 37, "from": 17, "beatId": "5dcf97d8-ba04-4814-afdf-fb959b01651c", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "Growth strategy, acquisition details, and financial projections", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dcea-728d-951c-3245f1025a1c", "docSlug": "00ac2b00f11c51b783403963865f2f9f", "documentTitle": "Truist Financial Corp | Results Presentation Deck | 37 slides", "authorId": "truist-financial-corp", "authorName": "Truist", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide uses a stepped, ascending visual structure to represent the pillars of the investment thesis.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dcea-728d-951c-3245f1025a1c/19", "deckHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c", "deckAnchorHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c#slide-19", "loopMatches": [ { "to": 26, "from": 17, "name": "Hypothesis Test", "slug": "42-hypothesis-test", "bestFor": "Strategy validation, due diligence, research presentations", "matchId": "af624d3e-dc9e-461f-9693-74b58a80801b", "evidence": "Acquisition details and financial projections", "position": 1, "objective": "Providing evidence and projections to support growth strategy", "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)", "confidence": 0.6, "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence" } ], "arcBeatMatches": [ { "to": 37, "from": 17, "beatId": "5dcf97d8-ba04-4814-afdf-fb959b01651c", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "Growth strategy, acquisition details, and financial projections", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dcea-728d-951c-3245f1025a1c", "docSlug": "00ac2b00f11c51b783403963865f2f9f", "documentTitle": "Truist Financial Corp | Results Presentation Deck | 37 slides", "authorId": "truist-financial-corp", "authorName": "Truist", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "appendix", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dcea-728d-951c-3245f1025a1c/20", "deckHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c", "deckAnchorHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c#slide-20", "loopMatches": [ { "to": 26, "from": 17, "name": "Hypothesis Test", "slug": "42-hypothesis-test", "bestFor": "Strategy validation, due diligence, research presentations", "matchId": "af624d3e-dc9e-461f-9693-74b58a80801b", "evidence": "Acquisition details and financial projections", "position": 1, "objective": "Providing evidence and projections to support growth strategy", "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)", "confidence": 0.6, "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence" } ], "arcBeatMatches": [ { "to": 37, "from": 17, "beatId": "5dcf97d8-ba04-4814-afdf-fb959b01651c", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "Growth strategy, acquisition details, and financial projections", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dcea-728d-951c-3245f1025a1c", "docSlug": "00ac2b00f11c51b783403963865f2f9f", "documentTitle": "Truist Financial Corp | Results Presentation Deck | 37 slides", "authorId": "truist-financial-corp", "authorName": "Truist", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Includes footnotes (1) and (2) regarding data exclusions and reporting basis.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dcea-728d-951c-3245f1025a1c/21", "deckHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c", "deckAnchorHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c#slide-21", "loopMatches": [ { "to": 26, "from": 17, "name": "Hypothesis Test", "slug": "42-hypothesis-test", "bestFor": "Strategy validation, due diligence, research presentations", "matchId": "af624d3e-dc9e-461f-9693-74b58a80801b", "evidence": "Acquisition details and financial projections", "position": 1, "objective": "Providing evidence and projections to support growth strategy", "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)", "confidence": 0.6, "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence" } ], "arcBeatMatches": [ { "to": 37, "from": 17, "beatId": "5dcf97d8-ba04-4814-afdf-fb959b01651c", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "Growth strategy, acquisition details, and financial projections", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dcea-728d-951c-3245f1025a1c", "docSlug": "00ac2b00f11c51b783403963865f2f9f", "documentTitle": "Truist Financial Corp | Results Presentation Deck | 37 slides", "authorId": "truist-financial-corp", "authorName": "Truist", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes income statement and balance sheet data with linked quarter and like quarter changes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dcea-728d-951c-3245f1025a1c/22", "deckHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c", "deckAnchorHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c#slide-22", "loopMatches": [ { "to": 26, "from": 17, "name": "Hypothesis Test", "slug": "42-hypothesis-test", "bestFor": "Strategy validation, due diligence, research presentations", "matchId": "af624d3e-dc9e-461f-9693-74b58a80801b", "evidence": "Acquisition details and financial projections", "position": 1, "objective": "Providing evidence and projections to support growth strategy", "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)", "confidence": 0.6, "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence" } ], "arcBeatMatches": [ { "to": 37, "from": 17, "beatId": "5dcf97d8-ba04-4814-afdf-fb959b01651c", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "Growth strategy, acquisition details, and financial projections", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dcea-728d-951c-3245f1025a1c", "docSlug": "00ac2b00f11c51b783403963865f2f9f", "documentTitle": "Truist Financial Corp | Results Presentation Deck | 37 slides", "authorId": "truist-financial-corp", "authorName": "Truist", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes non-GAAP reconciliation note at the bottom.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dcea-728d-951c-3245f1025a1c/23", "deckHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c", "deckAnchorHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c#slide-23", "loopMatches": [ { "to": 26, "from": 17, "name": "Hypothesis Test", "slug": "42-hypothesis-test", "bestFor": "Strategy validation, due diligence, research presentations", "matchId": "af624d3e-dc9e-461f-9693-74b58a80801b", "evidence": "Acquisition details and financial projections", "position": 1, "objective": "Providing evidence and projections to support growth strategy", "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)", "confidence": 0.6, "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence" } ], "arcBeatMatches": [ { "to": 37, "from": 17, "beatId": "5dcf97d8-ba04-4814-afdf-fb959b01651c", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "Growth strategy, acquisition details, and financial projections", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dcea-728d-951c-3245f1025a1c", "docSlug": "00ac2b00f11c51b783403963865f2f9f", "documentTitle": "Truist Financial Corp | Results Presentation Deck | 37 slides", "authorId": "truist-financial-corp", "authorName": "Truist", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "appendix_data", "function": "analyze_data", "notes": "The table tracks beginning balances, accretion/amortization, and ending balances across five quarters.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dcea-728d-951c-3245f1025a1c/24", "deckHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c", "deckAnchorHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c#slide-24", "loopMatches": [ { "to": 26, "from": 17, "name": "Hypothesis Test", "slug": "42-hypothesis-test", "bestFor": "Strategy validation, due diligence, research presentations", "matchId": "af624d3e-dc9e-461f-9693-74b58a80801b", "evidence": "Acquisition details and financial projections", "position": 1, "objective": "Providing evidence and projections to support growth strategy", "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)", "confidence": 0.6, "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence" } ], "arcBeatMatches": [ { "to": 37, "from": 17, "beatId": "5dcf97d8-ba04-4814-afdf-fb959b01651c", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "Growth strategy, acquisition details, and financial projections", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dcea-728d-951c-3245f1025a1c", "docSlug": "00ac2b00f11c51b783403963865f2f9f", "documentTitle": "Truist Financial Corp | Results Presentation Deck | 37 slides", "authorId": "truist-financial-corp", "authorName": "Truist", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes historical data and projections (marked with E).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dcea-728d-951c-3245f1025a1c/25", "deckHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c", "deckAnchorHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c#slide-25", "loopMatches": [ { "to": 26, "from": 17, "name": "Hypothesis Test", "slug": "42-hypothesis-test", "bestFor": "Strategy validation, due diligence, research presentations", "matchId": "af624d3e-dc9e-461f-9693-74b58a80801b", "evidence": "Acquisition details and financial projections", "position": 1, "objective": "Providing evidence and projections to support growth strategy", "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)", "confidence": 0.6, "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence" } ], "arcBeatMatches": [ { "to": 37, "from": 17, "beatId": "5dcf97d8-ba04-4814-afdf-fb959b01651c", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "Growth strategy, acquisition details, and financial projections", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dcea-728d-951c-3245f1025a1c", "docSlug": "00ac2b00f11c51b783403963865f2f9f", "documentTitle": "Truist Financial Corp | Results Presentation Deck | 37 slides", "authorId": "truist-financial-corp", "authorName": "Truist", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes disclaimer regarding forward curve assumptions and rounding.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dcea-728d-951c-3245f1025a1c/26", "deckHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c", "deckAnchorHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c#slide-26", "loopMatches": [ { "to": 26, "from": 17, "name": "Hypothesis Test", "slug": "42-hypothesis-test", "bestFor": "Strategy validation, due diligence, research presentations", "matchId": "af624d3e-dc9e-461f-9693-74b58a80801b", "evidence": "Acquisition details and financial projections", "position": 1, "objective": "Providing evidence and projections to support growth strategy", "structure": "The Hypothesis -> Test 1 (Supports/Refutes) -> Test 2 (Supports/Refutes) -> Conclusion (Validated/Pivoted)", "confidence": 0.6, "description": "State a hypothesis upfront, then systematically prove or disprove it with evidence" } ], "arcBeatMatches": [ { "to": 37, "from": 17, "beatId": "5dcf97d8-ba04-4814-afdf-fb959b01651c", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "Growth strategy, acquisition details, and financial projections", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dcea-728d-951c-3245f1025a1c", "docSlug": "00ac2b00f11c51b783403963865f2f9f", "documentTitle": "Truist Financial Corp | Results Presentation Deck | 37 slides", "authorId": "truist-financial-corp", "authorName": "Truist", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dcea-728d-951c-3245f1025a1c/27", "deckHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c", "deckAnchorHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c#slide-27", "loopMatches": [], "arcBeatMatches": [ { "to": 37, "from": 17, "beatId": "5dcf97d8-ba04-4814-afdf-fb959b01651c", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "Growth strategy, acquisition details, and financial projections", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dcea-728d-951c-3245f1025a1c", "docSlug": "00ac2b00f11c51b783403963865f2f9f", "documentTitle": "Truist Financial Corp | Results Presentation Deck | 37 slides", "authorId": "truist-financial-corp", "authorName": "Truist", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "appendix_disclosure", "function": "appendix", "notes": "Includes footnote (1) explaining the nature of the non-GAAP adjustments.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dcea-728d-951c-3245f1025a1c/28", "deckHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c", "deckAnchorHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c#slide-28", "loopMatches": [], "arcBeatMatches": [ { "to": 37, "from": 17, "beatId": "5dcf97d8-ba04-4814-afdf-fb959b01651c", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "Growth strategy, acquisition details, and financial projections", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-dcea-728d-951c-3245f1025a1c", "docSlug": "00ac2b00f11c51b783403963865f2f9f", "documentTitle": "Truist Financial Corp | Results Presentation Deck | 37 slides", "authorId": "truist-financial-corp", "authorName": "Truist", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide provides a detailed breakdown of adjustments made to GAAP noninterest expense and revenue to arrive at an adjusted efficiency ratio.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de073-dcea-728d-951c-3245f1025a1c/29", "deckHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c", "deckAnchorHref": "/decks/019de073-dcea-728d-951c-3245f1025a1c#slide-29", "loopMatches": [], "arcBeatMatches": [ { "to": 37, "from": 17, "beatId": "5dcf97d8-ba04-4814-afdf-fb959b01651c", "arcName": "Monroe's Motivated Sequence", "arcSlug": "monroes-sequence", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "Growth strategy, acquisition details, and financial projections", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }